Enveric Biosciences, Inc.
ENVB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000890821
No open-market purchases or sales by Enveric Biosciences, Inc. insiders were filed in the last 90 days; 24 institutions reported holding it in 13F filings for Q2 2026, worth $736.8K in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Enveric Biosciences, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 27 | 12 | −15 |
| SharesConverted for a 1-for-50 split | 186.2K | 147.6K | −38.6K (−20.7%) |
| Value | $1.99M | $623.0K | −$1.37M (−68.8%) |
New holders (1)
Institutions that held Enveric Biosciences, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bank of America Corp | 100 | $0 | 0.00% |
Sold out (16)
Institutions that held Enveric Biosciences, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Renaissance Technologies LLC | 1,092,098 | $234.0K |
| Millennium Management LLC | 227,618 | $49.0K |
| Ikarian Capital, LLC | 223,834 | $48.0K |
| Geode Capital Management, LLC | 204,569 | $43.0K |
| Virtu Financial LLC | 166,560 | $36.0K |
| State Street Corp | 90,634 | $19.0K |
| Northern Trust Corp | 36,504 | $8.00K |
| Scotia Capital Inc. | 26,580 | $6.00K |
| Engineers Gate Manager LP | 25,824 | $6.00K |
| Veritable, L.P. | 20,000 | $4.00K |
| Creative Planning | 17,577 | $4.00K |
| HRT Financial LP | 13,698 | $2.00K |
| Two Sigma Advisers, LP | 10,400 | $2.00K |
| Cutler Group LP | 5,600 | $1.00K |
| Credit Suisse AG | 1 | $0 |
| Simplex Trading, LLC | 1,400 | $0 |